Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

TRXBTRex Bio, Inc.

Nasdaq · CIK 0002139097
Filer category<br>Emerging growth company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts122

Identity from submissions API

NameTRex Bio, Inc.
CIK0002139097
TickersTRXB
ExchangesNasdaq
Entity typeoperating
Category<br>Emerging growth company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN000000000
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(650) 567-5582
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
C/O TREX BIO, INC.
269 EAST GRAND AVENUE SUITE 300
SOUTH SAN FRANCISCO
CA
CA
Mailing address
C/O TREX BIO, INC.
269 EAST GRAND AVENUE SUITE 300
SOUTH SAN FRANCISCO
CA
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

40 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-13 10-Q 10-Q 0001193125-26-460786 001-43501 261553163 34 9119130 1 1
2026-11-13 8-K 8-K 2.02,9.01 0001193125-26-460588 001-43501 261552303 34 399852 1 1
2026-10-16 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000078003-26-000118 005-95966 261467173 34 17925
2026-10-16 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0000059478-26-000095 005-95966 261466297 34 183893
2026-10-16 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001829126-26-011242 005-95966 261465978 34 51479
2026-10-15 4 FORM 4 0001722024-26-000004 10648
2026-10-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000904454-26-000517 005-95966 261462492 34 14105
2026-10-13 4 4 0001193125-26-420734 6966
2026-10-13 8-K 8-K 5.03,9.01 0001193125-26-420588 001-43501 261457486 34 440598 1 1
2026-10-13 4 FORM 4 0001829126-26-011084 32902
2026-10-09 S-8 S-8 0001193125-26-419221 333-299406 261453745 33 355324 1 1
2026-10-09 424B4 424B4 0001193125-26-419203 333-299018 261453583 33 36039764
2026-10-08 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-003188 333-299018 261451063 33 1791
2026-10-08 3 FORM 3 0001829126-26-010932 16729
2026-10-08 4 4 0001193125-26-418302 5360
2026-10-08 4 4 0001193125-26-418298 5424
2026-10-08 4 4 0001193125-26-418296 5460
2026-10-08 4 4 0001193125-26-418293 5343
2026-10-08 4 4 0001193125-26-418292 5319
2026-10-08 4 4 0001193125-26-418291 5318
2026-10-08 3 3 0001193125-26-418287 21898
2026-10-08 3 3 0001193125-26-418286 19200
2026-10-08 3 3 0001193125-26-418285 26215
2026-10-08 3 3 0001193125-26-418283 5720
2026-10-08 3 3 0001193125-26-418280 22244
2026-10-08 3 3 0001193125-26-418279 20087
2026-10-08 3 3 0001193125-26-418276 25310
2026-10-08 3 3 0001193125-26-418274 24106
2026-10-08 3 3 0001193125-26-418271 20449
2026-10-08 3 3 0001193125-26-418270 21353
2026-10-08 3 3 0001193125-26-418269 22321
2026-10-08 3 FORM 3 0000059478-26-000094 4599
2026-10-08 3 FORM 3 0001722024-26-000002 5906
2026-10-08 CERT 8A_Cert_2139097.pdf 0001354457-26-000964 001-43501 261449601 34 181540
2026-10-06 8-A12B 8-A12B 0001193125-26-415520 001-43501 261443897 34 33368
2026-10-05 S-1/A S-1/A 0001193125-26-413060 333-299018 261438731 33 43295133 1 1
2026-09-18 S-1 S-1 0001193125-26-395671 333-299018 261391568 33 38383518 1 1
2026-08-21 DRS/A filename1.htm 0001193125-26-361330 377-09512 261305861 33 36756094
2026-07-31 DRS/A filename1.htm 0001193125-26-328889 377-09512 261229604 33 23574987
2026-06-26 DRS filename1.htm 0001193125-26-285714 377-09512 261130486 33 20606580

Latest XBRL company facts

One latest value per concept from companyfacts (122 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 28.79M 2026-11-05 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
ffd NetFeeAmt NetFeeAmt USD 4,263.55 2026-10-08 S-8 2026-10-09 0001193125-26-419221
ffd TtlFeeAmt TtlFeeAmt USD 4,263.55 2026-10-08 S-8 2026-10-09 0001193125-26-419221
ffd TtlOfferingAmt TtlOfferingAmt USD 49.01M 2026-10-08 S-8 2026-10-09 0001193125-26-419221
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-10-08 S-8 2026-10-09 0001193125-26-419221
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 13,810 2026-10-03 S-1/A 2026-10-05 0001193125-26-413060
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 1.72M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 1.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 8.10M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -151,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 2.85M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 5.20M 2026-10-13 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 522,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 20.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap Assets Assets USD 88.75M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap AssetsCurrent Assets, Current USD 79.85M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 61.34M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 426,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 16.81M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 78.20M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 16.97M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 1.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 3.62M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 89.00M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 1.50M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 1.50M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap CommonStockValue Common Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -42.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 0 2025-12-31 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 4.60M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap Depreciation Depreciation USD 176,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap Dividends Dividends USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -34.02 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -34.02 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 2.51M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 2.00M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 7.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -42.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 100,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 130,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 636,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap IncreaseDecreaseInAccruedIncomeTaxesPayable Increase (Decrease) in Income Taxes Payable USD 128,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 2.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -848,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 61,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -1.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap InterestReceivable Interest Receivable USD 300,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 2.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap LeaseCost Lease, Cost USD 1.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 3.17M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.44M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1.74M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 360,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap Liabilities Liabilities USD 14.03M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 88.75M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap LiabilitiesCurrent Liabilities, Current USD 10.53M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD -3,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 47.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -7.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -37.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -42.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap NetRentableArea Net Rentable Area sqft 33,780 2026-04-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 2.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap NumberOfOperatingSegments Number of Operating Segments Segments 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap NumberOfReportableSegments Number of Reportable Segments Segments 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap OperatingExpenses Operating Expenses USD 44.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -44.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap OperatingLeaseCost Operating Lease, Cost USD 1.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 2.81M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 717,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 2.10M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap OperatingLeasePayments Operating Lease, Payments USD 900,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 2.73M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 1.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 748,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 5.35M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD -168,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap OtherGeneralAndAdministrativeExpense Other General and Administrative Expense USD 2.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 103,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -6,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 23.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap OtherSellingGeneralAndAdministrativeExpense Other Selling, General and Administrative Expense USD 6.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 177,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 81.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 93,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 1.70M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 255,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock Proceeds from Issuance of Redeemable Convertible Preferred Stock USD 50.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 74.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 826,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 37.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap RestrictedCash Restricted Cash USD 160,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -136.81M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 2.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 522,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 13.99M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 1.09M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 1.18 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 890,790 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 36.39M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 2.85M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 1.23 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 36.39M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 2.85M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 1.23 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 1.19 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 1.28 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -134.11M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 216,139 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 149,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 178,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap TaxesPayableCurrentAndNoncurrent Taxes Payable USD 1.30M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2026-01-31 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 68.57M 2026-01-31 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap VariableLeaseCost Variable Lease, Cost USD 130,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 1.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 1.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460786

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →